Synthesis and inhibitory activity of new benzimidazole derivatives against Burkitt's lymphoma promotion

Bioorganic and Medicinal Chemistry

Volumn 15, Issue 19, 2007, Pages 6489-6496

  Ramla, Mostafa M ^a   Omar, Mohamed A ^a   Tokuda, H ^b   El Diwani, Hoda I ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Benzimidazoles; EBV EA induction; Schiff bases; Thiazolidinone

Indexed keywords

1 (1 BENZYL 2 METHYL 1H BENZIMIDAZOL 5 YL) 3 METHYLTHIOUREA; 2 (1 BENZYL 2 METHYL 1H BENZIMIDAZOL 5 YLIMINO) 3 (4 METHOXYPHENYL)THIAZOLIDIN 4 ONE; 3 BENZOYL 2 (1 BENZYL 2 METHYL 1H BENZIMIDAZOL 5 YLIMINO)THIAZOLIDIN 4 ONE; BENZIMIDAZOLE DERIVATIVE; EPSTEIN BARR VIRUS ANTIGEN; PHORBOL 13 ACETATE 12 MYRISTATE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BURKITT LYMPHOMA; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; EPSTEIN BARR VIRUS; INFRARED SPECTROSCOPY; MELTING POINT; PROTON NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS; STRUCTURE ANALYSIS;

ANTIVIRAL AGENTS; BENZIMIDAZOLES; BURKITT LYMPHOMA; HUMANS; IMINES; OLEIC ACIDS; PHORBOL ESTERS; STRUCTURE-ACTIVITY RELATIONSHIP; THIAZOLIDINEDIONES; TUMOR CELLS, CULTURED; VIRUS ACTIVATION;

HUMAN HERPESVIRUS 4;

EID: 34547685944     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2007.04.010     Document Type: Article

References (23)

1. Desai G.K., and Desai R.K. J. Saudi Chem. Soc. 9 (2006) 631-640
2. Desai G.K., and Desai R.K. J. Sulfur Chem. 27 (2006) 315-328
3. Desai G.K., and Desai R.K. Bioorg. Med. Chem. 14 (2006) 8271-8279
4. Skibo E.B., and Schulz W.G. J. Med. Chem. 36 (1993) 3050
5. Skibo, E. B. U.S. Patent 5,015,742, 1991; Chem. Abstr. 1991, 115, 183297n.
6. Islam I., and Skibo E.B. J. Org. Chem. 55 (1990) 3195
7. Islam I., Skibo E.B., Dorr R.T., and Alberts D.S. J. Med. Chem. 34 (1991) 2954
8. Boruah R.C., and Skibo E.B. J. Med. Chem. 37 (1994) 1625
9. Schulz W.G., Islam I., and Skibo E.B. J. Med. Chem. 38 (1995) 109
10. Bapat D.G., and Shirsat M.V. Indian J. Chem. 3 (1965) 81
11. Kazimiercuk Z., and Shugar D. Nucleosides Nucleotides 8 (1989) 1379
12. Tolner B., Hartly J.A., and Hochhauser D. Mol. Pharmacol. 59 (2001) 699
13. Kraut E., Fleming T., Segal M., Neidhart J., and Behrens B.C. J. Invest. New Drugs 9 (1999) 95
14. Andrzejewska M., Mulia L.Y., Rivera R.C., Tapia A., Vilpo L., and Kazimierezuk Z. Eur. J. Med. Chem. 37 (2002) 973
15. Ramla M.M., Omar M.A., and El-Khamry A.-M.M. Bioorg. Med. Chem. 14 (2006) 7324-7332
16. El-Naem Sh.I., El-Nazhawy A.O., El-Diwani H.I., and Abdel Hamid A.O. Arch. Pharm. Pharm. Med. Chem. 1 (2003) 7
17. El-Naem Sh.I., El-Nazhawy A.O., El-Diwani H.I., and Abdel Hamid A.O. Mans. Sci. Bull. (A chem.). 28 (2002) 325
18. Goldstein M.B., Taku sagaua F., Berman M.H., Srivastava C.P., and Robins K.R. J. Am. Chem. Soc. 105 (1983) 7416-7422
19. Ottama R., Carotti S., Maccari R., Landini I., Chiricosta G., Cacigli B., Vigorita G.M., and Mini E. Bioorg. Med. Chem. Lett. 15 (2005) 3930-3933
20. Bapat D.G., and Shirat M.V. Indian J. Chem. 3 (1965) 81
21. Ito Y., Yanase S., Fujita J., Harayama T., Takashima M., and Imanaka H. Cancer Lett. 13 (1986) 29
22. Ohigashi H., Takamura H., Koshimizu K., Tokuda H., and Ito Y. Cancer Lett. 30 (1986) 143
23. Henle G., and Henle W. J. Bacteriol. 91 (1996) 1248